Page 3 - Qatar Genome Program News Today

Qatar aims to become a pioneer in genomics, with high investment in healthcare and a push to sequence 1 in 3of the Qatari population by 2026.

A round-up of the latest news from the Life Science industry; including news from the Pharmaceutical, Clinical Research, Biotechnology and Medical Device sectors from 23rd-27th May ...

Predictive Genomics is a significant field that can assist in anticipating illness risk and assess treatment responses.

Thermo Fisher Scientific, the world leader in serving science, and Qatar Genome Program (QGP), a member of Qatar Foundation (QF), have partnered with the goal of accelerating genomic research and clinical applications of predictive genomics in Qatar as a step toward expanding the benefits of precision medicine ...

The collaboration includes custom genotyping arrays designed to accelerate genomic research and clinical applications of predictive genomics across Arab populations

Doha: As part of its transformative learning culture, Hamad Bin Khalifa University (HBKU) develops an entrepreneurial mindset in its graduates and the...

Qatar s technology sector, which is set to expand further, offers immense opportunity for companies, said experts during a webinar. Tasmu Digital Vall...

A group of researchers at Qatar Foundation have reported the first comprehensive study of the distribution of actionable genetic variation affecting drugs in any Middle Eastern population, with potential implications for preemptive pharmacogenomic implementation in the region.

Doha, Qatar, February 9, 2022: A group of researchers at Qatar Foundation led by Dr. Lotfi Chouchane from Weill Cornell Medicine – Qatar (WCM-Q) have

Ancestry study tells the history of migrations and shapes the first genetic reference panel dedicated to Middle Eastern populations.